Symptoms of mesothelioma may go unrecognized, as they are often similar to common illnesses. However, early detection of mesothelioma is key to extending your life expectancy. Mesothelioma takes ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

UPDATE, Jan. 16 at 10:20 a.m.: Asante Health System and Dr. Charles Carmeci have paid $430,000 to settle allegations of Medicare fraud allegations. According to a news release from the Oregon district ...

Interventional radiology refers to radiologists treating disease with minimally invasive surgery. These surgeries are performed using radiologic images to guide small catheters. Because many of these ...

Malignant pleural effusion (MPE) is a common complication in the late stage of malignant tumors. The appearance of MPE indicates that the primary tumor has spread to the pleura or progressed to an ...

BD’s system can be used for malignant and non-malignant ascites drainage. Credit: SKreutz on Wikimedia. The US Food and Drug Administration (FDA) has expanded its 510(k) clearance for Becton, ...

Becton Dickinson & Co. (NYSE:BDX) said today that it won a $100 million contract from the U.S. Department of Defense for its Pyxis ES system. According to the contract, Franklin Lakes, N.J.-based BD ...

The FDA has cleared Becton Dickinson’s catheter system for the treatment of non-malignant, recurrent causes of pleural effusion, or the collection of fluid next to the lungs. This clearance expanded ...

Franklin Lakes, NJ /PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its PleurX™ catheter system received U.S. Food and Drug ...

Becton Dickinson & Co. (NYSE:BDX) said today it won expanded FDA 510(k) clearance for its PleurX catheter system. The PleurX catheter system is now cleared for use in treating non-malignant recurrent ...